News & Updates
Read latest news and updates related to AMP PD
- AMP PD in the news
- Advancements in research using AMP PD
- Grant and funding opportunities
- Program milestones and roadmap
Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease
The Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease.
Massive NIH–industry project opens portals to target validation
Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.
Accelerating research for Parkinson's disease
Despite considerable ongoing translational and clinical research efforts, no disease-modifying drugs have been approved for Parkinson's disease. The Accelerating Medicines Partnership Parkinson's disease (AMP PD) programme, launched on Jan 30, 2018, is the most ambitious initiative so far to find a cure for Parkinson's disease.